These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3938 related articles for article (PubMed ID: 4202157)

  • 21. In vitro lymphocyte stimulation by a soluble antigen from malignant melanoma.
    Jehn UW; Nathanson L; Schwartz RS; Skinner M
    N Engl J Med; 1970 Aug; 283(7):329-33. PubMed ID: 4193645
    [No Abstract]   [Full Text] [Related]  

  • 22. Mammalin tyrosinase. Stoichiometry and measurement of reaction products.
    Hearing VJ; Ekel TM; Montague PM; Nicholson JM
    Biochim Biophys Acta; 1980 Feb; 611(2):251-68. PubMed ID: 6766744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inability of murine melanoma melanosomal "tyrosinase" (L-dopa oxidase) to oxidize tyrosine to melanin in polyacrylamide gel systems.
    Edelstein LM; Cariglia N; Okun MR; Patel RP; Smucker D
    J Invest Dermatol; 1975 May; 64(5):364-70. PubMed ID: 806638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The tyrosinases of normal and diseased human skin (naevi, malignant melanoma, vitiligo).
    Voulot C; Ortonne JP
    Arch Dermatol Res (1975); 1975 Dec; 254(2):205-14. PubMed ID: 814859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification and characterization of a tyrosinase from Streptomyces glaucescens.
    Lerch K; Ettinger L
    Eur J Biochem; 1972 Dec; 31(3):427-37. PubMed ID: 4631007
    [No Abstract]   [Full Text] [Related]  

  • 26. Persistence and characterization of idiotypes in pedigreed rabbits producing antibodies of restricted heterogeneity to pneumococcal polysaccharides.
    Winfield JB; Pincus JH; Mage RG
    J Immunol; 1972 May; 108(5):1278-87. PubMed ID: 4112921
    [No Abstract]   [Full Text] [Related]  

  • 27. Inability of murine melanoma "tyrosinase" (dopa ozidase) to oxidize tyrosine in the presence or absence of dopa or dihydroxyfumarate cofactor.
    Patel RP; Okun MR; Yee WA; Wilgram GF; Edelstein LM
    J Invest Dermatol; 1973 Aug; 61(2):55-9. PubMed ID: 4199461
    [No Abstract]   [Full Text] [Related]  

  • 28. Tyrosinase activity in serum from normal and melanoma-bearing mice.
    Menon IA; Haberman HF
    Cancer Res; 1968 Jul; 28(7):1237-41. PubMed ID: 4969868
    [No Abstract]   [Full Text] [Related]  

  • 29. Purification and properties of tyrosinase isoenzymes from hamster melanoma.
    Pomerantz SH; Li JP
    Yale J Biol Med; 1973 Dec; 46(5):541-52. PubMed ID: 4205121
    [No Abstract]   [Full Text] [Related]  

  • 30. Particulate nature of o-diphenoloxidase in Mycobacterium leprae and assay of the enzyme by the radioisotope technique.
    Prabhakaran K; Harris EB; Kirchheimer WF
    Microbios; 1973; 8(30):151-7. PubMed ID: 4204390
    [No Abstract]   [Full Text] [Related]  

  • 31. 5,6-Dihydroxyindole oxidation by mammalian, mushroom and amphibian tyrosinase preparations.
    Miranda M; Botti D; Bonfigli A; Arcadi A
    Biochim Biophys Acta; 1985 Aug; 841(2):159-65. PubMed ID: 3926006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High level of alpha-fetoprotein in sera of adult mice.
    Pihko H; Ruoslahti E
    Int J Cancer; 1973 Sep; 12(2):354-60. PubMed ID: 4134123
    [No Abstract]   [Full Text] [Related]  

  • 33. Solubilization and activation of mammalian melanoma particulate tyrosinase by lipase digestion.
    Chen YM
    Cancer Res; 1974 Dec; 34(12):3192-6. PubMed ID: 4214611
    [No Abstract]   [Full Text] [Related]  

  • 34. The isolation and characterization of an anti-sheep red blood cell antibody having limited heterogeneity.
    Bratcher RL; Chong CA; Dray S
    J Immunol; 1974 Apr; 112(4):1337-46. PubMed ID: 4205526
    [No Abstract]   [Full Text] [Related]  

  • 35. [Heterogeneity of mammalian tyrosinases].
    Pavel S; Vachtenheim J
    Cesk Fysiol; 1979; 28(6):491-505. PubMed ID: 117908
    [No Abstract]   [Full Text] [Related]  

  • 36. Regulatory mechanisms of tyrosinase activity in melanocyte. I.
    Seiji M; Fukuzawa H; Miyazaki N; Akiba H; Kato T
    Yale J Biol Med; 1973 Dec; 46(5):508-15. PubMed ID: 4205118
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunologic evaluation of the cancer patient during immunotherapy.
    Boehm OR; Boehm BJ; Jewell WR; Humphrey LJ
    Natl Cancer Inst Monogr; 1972 Dec; 35():403-8. PubMed ID: 4633407
    [No Abstract]   [Full Text] [Related]  

  • 38. Separation of different serological activities associated with immunoglobulins from sera of rabbits immunized with rat erythrocytes.
    Kastelan M; Vitale L; Vitale B
    Eur J Immunol; 1971 Nov; 1(5):363-6. PubMed ID: 5003356
    [No Abstract]   [Full Text] [Related]  

  • 39. The tyrosinase-protyrosinase system in frog epidermis.
    McGuire J; Newman D; Barisas G
    Yale J Biol Med; 1973 Dec; 46(5):572-82. PubMed ID: 4205123
    [No Abstract]   [Full Text] [Related]  

  • 40. Further characterization of the apolipoproteins of rat plasma lipoproteins.
    Bersot TP; Brown WV; Levy RI; Windmueller HG; Fredrickson DS; LeQuire VS
    Biochemistry; 1970 Aug; 9(17):3427-33. PubMed ID: 5001326
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 197.